41st European Mutagen Meeting

41è Congrés de la Societat Europea de Mutagènesi

Researchers María Blasco, director of CNIO (National Centre for Oncological Research) and Manel Esteller, director of PEBC-IDIBELL (Cancer Epigenetics and Biology Programme of the Biomedical Research Institute, Bellvitge) will offer the opening and closing speeches at the 41st European Mutagen Annual Meeting, taking place in Barcelona from 4 to 7 July. The event is organised by Dr Jordi Surrallés, professor of the Department of Genetics and Microbiology at Universitat Autònoma de Barcelona (UAB) and member of CIBER Rare Diseases (CIBERER), in representation of the European Environmental Mutagen Society (EEMS).

01/07/2011

A total of 65 conferences will be held by experts from different European countries who will be presenting the latest studies in subjects related to genome stability, molecular oncology, the origin of mutations, the effect and detection of mutagen agents and their potential to induce cancer.

Conferences are structured into different sessions such as DNA reparation, personalised cancer therapies, rare diseases causing tumours, genotoxicity of nanoparticles, genetic toxicology in pharmaceutical and chemical industries, and studies of populations exposed to carcinogenics.

Before beginning the conference, which will be held at the Hotel Centre de Convencions Fira Palace in Barcelona, a work session on statistics in genetic toxicology will take place.

UAB, through the Vice Rectorate for Research, and CIBERER sponsor the Annual Meeting, together with the Ministry for Science and Innovation, the Spanish Genome Foundation and AGAUR (Agency of University and Research Grants). Support from other institutions and companies from the pharmaceutical, chemical and biotechnology sector include BioReliance, Covance, ECETOC (European Centre for Ecotoxicology and Toxicologic of Chemicals), Elsevier, FCI (Fonds der Chemischen Industrie), Hesi, Gentronix, Givaudan, GlaxoSmithKline, Harlan, Huntingdon, L'Oreal, MetaSystems, Novartis, Perceptive Instruments, Pfizer, Sanofi aventis, Trinova Biochem, UKEMS (United Kingdom Environmental Mutagen Society) and Unilever.

Full 41st European Mutagen Meeting Programme

European Environmental Mutagen Society